A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy.

[1]  C. Faivre-Finn,et al.  The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust. , 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  N. Burnet,et al.  Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas. , 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  A. Lomax,et al.  Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy , 2020, Radiation Oncology.

[4]  A. Snijders,et al.  A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. , 2020, International journal of radiation oncology, biology, physics.

[5]  D. Thwaites,et al.  Particle therapy toxicity outcomes: A systematic review , 2020, Journal of medical imaging and radiation oncology.

[6]  D. Thwaites,et al.  Particle therapy tumour outcomes: An updated systematic review , 2020, Journal of medical imaging and radiation oncology.

[7]  B. Yeap,et al.  An open invitation to join the pediatric proton/photon consortium registry to standardize data collection in pediatric radiation oncology. , 2020, The British journal of radiology.

[8]  B. Timmermann,et al.  Paediatric proton therapy. , 2020, The British journal of radiology.

[9]  T. Yock,et al.  The role of proton therapy in pediatric malignancies: Recent advances and future directions. , 2020, Seminars in oncology.

[10]  N. Iles,et al.  TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  J. Metz,et al.  Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. , 2019, JAMA oncology.

[12]  R. Mackay,et al.  Proton beam therapy - perspectives on the National Health Service England clinical service and research programme. , 2019, The British journal of radiology.

[13]  W. Whitehead,et al.  Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  I. Toma-Dasu,et al.  Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment related toxicities following proton therapy for intracranial tumors. , 2019, Medical physics.

[15]  E. Hall,et al.  Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy , 2019, Clinical and translational radiation oncology.

[16]  D. Georg,et al.  Bringing Europe together in building clinical evidence for proton therapy – the EPTN–ESTRO–EORTC endeavor , 2019, Acta oncologica.

[17]  M. Limb.  How NHS investment in proton beam therapy is coming to fruition , 2019, British medical journal.

[18]  Roberto Orecchia,et al.  Prospective data registration and clinical trials for particle therapy in Europe. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  B. Yeap,et al.  An Update From the Pediatric Proton Consortium Registry , 2018, Front. Oncol..

[20]  N. Kirkby,et al.  Mathematical Modelling for Patient Selection in Proton Therapy. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  B. Jones,et al.  The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  A. van der Schaaf,et al.  Clinical Trial Strategies to Compare Protons With Photons. , 2018, Seminars in radiation oncology.

[23]  C. Simone,et al.  Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review , 2018, Journal of the National Cancer Institute.

[24]  C. Ronckers,et al.  A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy. , 2017, International journal of radiation oncology, biology, physics.

[25]  Marco Durante,et al.  Charged-particle therapy in cancer: clinical uses and future perspectives , 2017, Nature Reviews Clinical Oncology.

[26]  T. Terunuma,et al.  A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors , 2017, Radiation oncology.

[27]  N. Burnet,et al.  Proton beam therapy: the context, future direction and challenges become clearer. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  Steve Clarke,et al.  Position statement on ethics, equipoise and research on charged particle radiation therapy , 2013, Journal of Medical Ethics.

[29]  Johannes A Langendijk,et al.  Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Mohammad Hassan Murad,et al.  Controversies in clinical trials in proton radiotherapy: the present and the future. , 2013, Seminars in radiation oncology.

[31]  M. Rawlins.  De testimonio: on the evidence for decisions about the use of therapeutic interventions , 2008, The Lancet.

[32]  J. Welsh,et al.  Basics of Particle Therapy: Introduction to Hadrons , 2008, American journal of clinical oncology.

[33]  Søren M Bentzen,et al.  Randomized controlled trials in health technology assessment: overkill or overdue? , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  J. Cox,et al.  Should randomized clinical trials be required for proton radiotherapy? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Damien C Weber,et al.  A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. , 2003, International journal of radiation oncology, biology, physics.

[36]  R. Bristow,et al.  MyChristie-MyHealth: introducing electronic patient reported outcome measures (ePROMs) in routine practice to revolutionise cancer care , 2020 .

[37]  Zuofeng Li,et al.  Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.